External Advisory Boards
We have three independent external advisory boards in CANDY.
Scientific Advisory Board
Prof. Dr. Dr. Tobias Banaschewski
Professor of Child and Adolescent Psychiatry
Expert in neuroscience and clinic of ADHD
Prof. Dr. Hilde van Esch
Professor for clinical genetics
Expert in clinical genetics, intellectual disability, neurodevelopmental disorders, syndromology
Prof. Janet Mifsud de Gray
Professor of Clinical Pharmacology and Therapeutics
Expert in neuropharmacology, epilepsy, pharmacokinetics and pharmacodynamics, toxicology, advocacy with patient organisations.
Prof. Annamaria Vezzani, PhD
Head of the Laboratory of Experimental Neurology
Expert in preclinical and translational research in animal models of epilepsy
Ethics Advisory Board
Prof. John Suckling
Director of Research in Psychiatric Neuroimaging
Expert in Neuroimaging and research ethics
Prof. Dr. Dirk Lanzerath
Professor of Ethics and Research Ethics
Expert in ethics, bioethics, research ethics, philosophy of biology
Prof. Marcella Rietschel
Director of Genetic Epidemiology in Psychiatry
Expert in ethical, legal, and social implications of psychiatric genetic research
PD Dr. Ulrike Schulze
Chief Physician and Research group leader
Expert in Eating disorders and comorbidities, Transition, Ethics
Exploitation and Innovation Management Board (EIMB)
Jacques Bauer, PhD
Scientific Director Innovation & Intellectual Property
Expert in IP, medicinal chemistry, immunology, microbiota,
data base mining, knowledge management
Lucas Noldus, Ph.D.
Founder and CEO Noldus Information Technology
As part of the “Horizon 2020” programme, the European Commission is funding the five-year CANDY research project with a total of six million Euro under grant agreement No. 847818.